Conclusion
Our results suggest that the atypical antipsychotic quetiapine is effective in children and adolescents with Tourette's syndrome for reducing tic severity, has a good safety profile and is well tolerated except for causing mild weight gain. However, we suggest that prospective double-blind controlled studies are required to further evaluate the effectiveness of quetiapine in the treatment of Tourette's syndrome.
The authors would like to thank Assoc. Prof. Peykan Gökalp, Bakirkoy State Teaching Hospital for Psychiatry and Neurology, Department of Anxiety Disorders and Psychotherapy, Istanbul, for reviewing the English translation of the manuscript.
Funding informationNo sources of funding were used to assist in the preparation of this study.
Dr Mazlum Copur, Osmaniye Cad. Goksu apt. 7/16 Bakirkoy, Istanbul, Turkey. E-mail: mazlum@dsl.ttnet.net.tr
Clin Drug Invest. 2007;27(2):123-130. © 2007 Adis Data Information BV
Comments